Details for Patent: 8,105,626
✉ Email this page to a colleague
Which drugs does patent 8,105,626 protect, and when does it expire?
Patent 8,105,626 protects DEXILANT and is included in one NDA.
Protection for DEXILANT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has seventeen patent family members in nine countries.
Summary for Patent: 8,105,626
Title: | Granules containing acid-unstable chemical in large amount |
Abstract: | It is intended to provide preparations such as capsules containing an acid-unstable medicament (in particular, a benzimidazole compound having an antiulcer effect, etc.) at a high concentration which are prepared by using about 12% by weight or more (based on the total granules) of the acid-unstable chemical and blending a basic inorganic salt therewith to give granules of about 600 .mu.m or more in the average particle size. |
Inventor(s): | Shimizu; Toshihiro (Itami, JP), Nakano; Yoshinori (Takarazuka, JP) |
Assignee: | Takeda Pharmaceutical Company Limited (Osaka, JP) |
Application Number: | 10/492,690 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,105,626 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Dosage form; Use; Composition; |
Drugs Protected by US Patent 8,105,626
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-002 | Jan 30, 2009 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,105,626
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Japan | 2001-319444 | Oct 17, 2001 |
PCT Information | |||
PCT Filed | October 16, 2002 | PCT Application Number: | PCT/JP02/10720 |
PCT Publication Date: | April 24, 2003 | PCT Publication Number: | WO03/032953 |
International Family Members for US Patent 8,105,626
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2463690 | ⤷ Try a Trial | |||
China | 100562317 | ⤷ Try a Trial | |||
China | 1571659 | ⤷ Try a Trial | |||
Cyprus | 1113763 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |